Sign In
Buy PGNY
$26.28
+0.200 (+0.767%)
At Close: Jun 22, 2026
Progyny, Inc. Announces Third Quarter 2025 Results
04:01pm, Thursday, 06'th Nov 2025
Reports Revenue of $313.3 Million, Reflecting 9.3% GrowthRaises Full Year Guidance to Reflect Continued Strength in Member EngagementSelling Season Yields Over 80 New Clients, 900,000 New Lives, and N
Analyzing Progyny (NASDAQ:PGNY) and CareDx (NASDAQ:CDNA)
02:30am, Wednesday, 05'th Nov 2025
Progyny (NASDAQ: PGNY - Get Free Report) and CareDx (NASDAQ: CDNA - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based
Y Intercept Hong Kong Ltd Buys 26,310 Shares of Progyny, Inc. $PGNY
04:03am, Tuesday, 04'th Nov 2025
Y Intercept Hong Kong Ltd lifted its stake in Progyny, Inc. (NASDAQ: PGNY) by 88.0% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5
Oppenheimer Asset Management Inc. Trims Stock Holdings in Progyny, Inc. $PGNY
04:05am, Sunday, 02'nd Nov 2025
Oppenheimer Asset Management Inc. reduced its stake in Progyny, Inc. (NASDAQ: PGNY) by 22.0% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange
Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of “Moderate Buy” by Brokerages
01:56am, Friday, 31'st Oct 2025
Shares of Progyny, Inc. (NASDAQ: PGNY - Get Free Report) have received an average rating of "Moderate Buy" from the ten ratings firms that are presently covering the firm, MarketBeat.com reports. Four
Progyny, Inc. Announces Details for Its Third Quarter 2025 Results Report
01:08pm, Thursday, 23'rd Oct 2025
NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women's health and family building solutions, will report its financial results for the quarterly period en
Are Investors Undervaluing Progyny (PGNY) Right Now?
10:41am, Thursday, 23'rd Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Progyny Expands Global Benefits to Include Pregnancy, Postpartum, and Menopause
09:28am, Wednesday, 22'nd Oct 2025
NEW YORK, Oct. 22, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc . (Nasdaq: PGNY), a global leader in women's health and family building solutions, today announced the launch of its pregnancy, postpartum, and
Analyzing Progyny (NASDAQ:PGNY) & Teladoc Health (NYSE:TDOC)
01:48am, Wednesday, 22'nd Oct 2025
Progyny (NASDAQ: PGNY - Get Free Report) and Teladoc Health (NYSE: TDOC - Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two businesses b
Is Progyny (PGNY) Stock Undervalued Right Now?
10:41am, Tuesday, 07'th Oct 2025
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Progyny CEO Named World Economic Forum Champion for Women's Health
09:30am, Tuesday, 07'th Oct 2025
Progyny joins global leaders to accelerate advancement in research, innovation, and resilience in women's health Progyny joins global leaders to accelerate advancement in research, innovation, and res
A Healthcare Debate: Progyny vs. Hims & Hers
08:05am, Friday, 26'th Sep 2025
In this podcast, Motley Fool analysts Alicia Alfiere, Sanmeet Deo, and Tim Beyers discuss:
Surging Earnings Estimates Signal Upside for Progyny (PGNY) Stock
01:20pm, Monday, 01'st Sep 2025
Progyny (PGNY) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Progyny, Inc. (PGNY) Q2 2025 Earnings Call Transcript
08:22pm, Thursday, 07'th Aug 2025
Progyny, Inc. (NASDAQ:PGNY ) Q2 2025 Earnings Conference Call August 7, 2025 4:45 PM ET Company Participants James Hart - Vice President of Investor Relations Mark S. Livingston - Chief Financial Offi
Progyny (PGNY) Tops Q2 Earnings and Revenue Estimates
07:20pm, Thursday, 07'th Aug 2025
Progyny (PGNY) came out with quarterly earnings of $0.48 per share, beating the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.43 per share a year ago.
